Increased Number of Mesenchymal Stem Cell-like Cells in Peripheral Blood of Patients with Bone Sarcomas

Archives of Medical Research

Volumn 40, Issue 3, 2009, Pages 163-168

  Bian, Zhen Yu ^a   Li, Gang ^b   Gan, Yao Kai ^a   Hao, Yong Qiang ^a   Xu, Wen Ting ^a   Tang, Ting Ting ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Bone sarcoma; Hepatocyte growth factor; Mesenchymal stem cells; Peripheral blood; Vascular endothelial growth factor

Indexed keywords

BETA GALACTOSIDASE; CD34 ANTIGEN; CD45 ANTIGEN; CYTOKINE; ENDOGLIN; LEPTIN; LIPOCORTIN 5; SCATTER FACTOR; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN;

ADULT; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CANCER CELL CULTURE; CANCER PATIENT; CELL AGING; CELL COUNT; CELL DEATH; CELL SEPARATION; CHONDROSARCOMA; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROSARCOMA; FLOW CYTOMETRY; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; MALE; MESENCHYMAL STEM CELL; OSTEOSARCOMA; PERIPHERAL BLOOD MONONUCLEAR CELL; PERIPHERAL BLOOD STEM CELL; PHENOTYPE; PLASMA; PROTEIN BLOOD LEVEL; STAINING;

ADOLESCENT; ADULT; ANNEXIN A5; APOPTOSIS; BETA-GALACTOSIDASE; BONE NEOPLASMS; CELL COUNT; CHEMOKINE CXCL12; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; LEPTIN; MALE; MESENCHYMAL STEM CELLS; MIDDLE AGED; SARCOMA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 67349283527     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2009.01.002     Document Type: Article

References (42)

1. Yue B., Lu B., Dai K.R., et al. BMP2 gene therapy on the repair of bone defects of aged rats. Calcif Tissue Int 77 (2005) 395-403
2. Deans R.J., and Moseley A.B. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 28 (2000) 875-884
3. Wexler S.A., Donaldson C., Denning-Kendall P., Rice C., Bradley B., and Hows J.M. Adult bone marrow is a rich source of human mesenchymal 'stem' cells but umbilical cord and mobilized adult blood are not. Br J Haematol 121 (2003) 368-374
4. Kuznetsov S.A., Mankani M.H., Gronthos S., Satomura K., Bianco P., and Robey P.G. Circulating skeletal stem cells. J Cell Biol 153 (2001) 1133-1140
5. He Q., Wan C., and Li G. Concise review: multipotent mesenchymal stromal cells in blood. Stem Cells 25 (2007) 69-77
6. Reading L., Still K., Bishop N., and Scutt A. Peripheral blood as an alternative source of mesenchymal stem cells. Bone 26 Suppl (2000) S9
7. Ramirez M., Lucia A., Gomez-Gallego F., et al. Mobilisation of mesenchymal cells into blood in response to skeletal muscle injury. Br J Sports Med 40 (2006) 719-722
8. Mansilla E., Marin G.H., Drago H., et al. Bloodstream cells phenotypically identical to human mesenchymal bone marrow stem cells circulate in large amounts under the influence of acute large skin damage: new evidence for their use in regenerative medicine. Transplant Proc 38 (2006) 967-969
9. Fernandez M., Simon V., Herrera G., Cao C., Del Favero H., and Minguell J.J. Detection of stromal cells in peripheral blood progenitor cell collections from breast cancer patients. Bone Marrow Transplant 20 (1997) 265-271
10. Kumagai K., Vasanji A., Drazba J.A., Butler R.S., and Muschler G.F. Circulating cells with osteogenic potential are physiologically mobilized into the fracture healing site in the parabiotic mice model. J Orthop Res 26 (2008) 165-175
11. Liechty K.W., MacKenzie T.C., Shaaban A.F., et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 6 (2000) 1282-1286
12. Mackenzie T.C., and Flake A.W. Human mesenchymal stem cells persist, demonstrate site-specific multipotential differentiation, and are present in sites of wound healing and tissue regeneration after transplantation into fetal sheep. Blood Cells Mol Dis 27 (2001) 601-604
13. Shirley D., Marsh D., Jordan G., McQuaid S., and Li G. Systemic recruitment of osteoblastic cells in fracture healing. J Orthop Res 23 (2005) 1013-1021
14. Li S., Tu Q., Zhang J., et al. Systemically transplanted bone marrow stromal cells contributing to bone tissue regeneration. J Cell Physiol 215 (2008) 204-209
15. Bissell M.J., and Radisky D. Putting tumours in context. Nat Rev Cancer 1 (2001) 46-54
16. Dvorak H.F. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315 (1986) 1650-1659
17. Studeny M., Marini F.C., Champlin R.E., Zompetta C., Fidler I.J., and Andreeff M. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res 62 (2002) 3603-3608
18. Studeny M., Marini F.C., Dembinski J.L., et al. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst 96 (2004) 1593-1603
19. Nakamizo A., Marini F., Amano T., et al. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 65 (2005) 3307-3318
20. Menon L.G., Picinich S., Koneru R., et al. Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells. Stem Cells 25 (2007) 520-528
21. Dimri G.P., Lee X., Basile G., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92 (1995) 9363-9367
22. Rochefort G.Y., Delorme B., Lopez A., et al. Multipotential mesenchymal stem cells are mobilized into peripheral blood by hypoxia. Stem Cells 24 (2006) 2202-2208
23. Bittira B., Shum-Tim D., Al-Khaldi A., and Chiu R.C. Mobilization and homing of bone marrow stromal cells in myocardial infarction. Eur J Cardiothorac Surg 24 (2003) 393-398
24. Seebach C., Henrich D., Tewksbury R., Wilhelm K., and Marzi I. Number and proliferative capacity of human mesenchymal stem cells are modulated positively in multiple trauma patients and negatively in atrophic nonunions. Calcif Tissue Int 80 (2007) 294-300
25. Sonobe H., Mizobuchi H., Manabe Y., et al. Morphological characterization of a newly established human osteosarcoma cell line, HS-Os-1, revealing its distinct osteoblastic nature. Virchows Arch B Cell Pathol Incl Mol Pathol 60 (1991) 181-187
26. Kunisada T., Miyazaki M., Mihara K., et al. A new human chondrosarcoma cell line (OUMS-27) that maintains chondrocytic differentiation. Int J Cancer 77 (1998) 854-859
27. van den Bos C., Silverstetter S., Murphy M., and Connolly T. p21(cip1) rescues human mesenchymal stem cells from apoptosis induced by low-density culture. Cell Tissue Res 293 (1998) 463-470
28. Casciola-Rosen L., Rosen A., Petri M., and Schlissel M. Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc Natl Acad Sci USA 93 (1996) 1624-1629
29. Baksh D., Davies J.E., and Zandstra P.W. Soluble factor cross-talk between human bone marrow-derived hematopoietic and mesenchymal cells enhances in vitro CFU-F and CFU-O growth and reveals heterogeneity in the mesenchymal progenitor cell compartment. Blood 106 (2005) 3012-3019
30. Holzer G., Obermair A., Koschat M., Preyer O., Kotz R., and Trieb K. Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with malignant bone tumors. Med Pediatr Oncol 36 (2001) 601-604
31. Rutkowski P., Kaminska J., Kowalska M., Ruka W., and Steffen J. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis. J Surg Oncol 84 (2003) 151-159
32. Chattopadhyay N., MacLeod R.J., Tfelt-Hansen J., and Brown E.M. 1α,25(OH)2-vitamin D3 inhibits HGF synthesis and secretion from MG-63 human osteosarcoma cells. Am J Physiol Endocrinol Metab 284 (2003) E219-E227
33. Slominski A., Wortsman J., Carlson A., Mihm M., Nickoloff B., and McClatchey K. Molecular pathology of soft tissue and bone tumors. A review. Arch Pathol Lab Med 123 (1999) 1246-1259
34. Charity R.M., Foukas A.F., Deshmukh N.S., and Grimer R.J. Vascular endothelial growth factor expression in osteosarcoma. Clin Orthop Relat Res 448 (2006) 193-198
35. Ozaki Y., Nishimura M., Sekiya K., et al. Comprehensive analysis of chemotactic factors for bone marrow mesenchymal stem cells. Stem Cells Dev 16 (2007) 119-129
36. Kilian O., Flesch I., Wenisch S., et al. Effects of platelet growth factors on human mesenchymal stem cells and human endothelial cells in vitro. Eur J Med Res 9 (2004) 337-344
37. Fiedler J., Leucht F., Waltenberger J., Dehio C., and Brenner R.E. VEGF-A and PlGF-1 stimulate chemotactic migration of human mesenchymal progenitor cells. Biochem Biophys Res Commun 334 (2005) 561-568
38. Lin H., Shabbir A., Molnar M., et al. Adenoviral expression of vascular endothelial growth factor splice variants differentially regulate bone marrow-derived mesenchymal stem cells. J Cell Physiol 216 (2008) 458-468
39. MacEwen E.G., Kutzke J., Carew J., et al. c-Met tyrosine kinase receptor expression and function in human and canine osteosarcoma cells. Clin Exp Metastasis 20 (2003) 421-430
40. Coltella N., Manara M.C., Cerisano V., et al. Role of the MET/HGF receptor in proliferation and invasive behavior of osteosarcoma. FASEB J 17 (2003) 1162-1164
41. Neuss S., Becher E., Woltje M., Tietze L., and Jahnen-Dechent W. Functional expression of HGF and HGF receptor/c-met in adult human mesenchymal stem cells suggests a role in cell mobilization, tissue repair, and wound healing. Stem Cells 22 (2004) 405-414
42. Son B.R., Marquez-Curtis L.A., Kucia M., et al. Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. Stem Cells 24 (2006) 1254-1264